Compare WTM & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WTM | STVN |
|---|---|---|
| Founded | 1980 | 1949 |
| Country | Bermuda | Italy |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Containers/Packaging |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 5.4B |
| IPO Year | 1994 | 2021 |
| Metric | WTM | STVN |
|---|---|---|
| Price | $2,217.25 | $16.05 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.75 |
| AVG Volume (30 Days) | 14.1K | ★ 944.1K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | 0.05% | ★ 0.40% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 105.18 | N/A |
| Revenue | ★ $2,239,800,000.00 | N/A |
| Revenue This Year | N/A | $8.42 |
| Revenue Next Year | N/A | $9.36 |
| P/E Ratio | ★ $21.18 | $27.15 |
| Revenue Growth | ★ 3.37 | N/A |
| 52 Week Low | $1,648.00 | $13.91 |
| 52 Week High | $2,246.88 | $28.00 |
| Indicator | WTM | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 65.48 | 42.01 |
| Support Level | $2,173.16 | $15.43 |
| Resistance Level | $2,246.88 | $16.50 |
| Average True Range (ATR) | 54.58 | 0.88 |
| MACD | 10.28 | 0.27 |
| Stochastic Oscillator | 85.44 | 75.68 |
White Mountains Insurance Group Ltd is engaged in the business of making opportunistic and value-oriented acquisitions of businesses and assets in the insurance, financial services, and related sectors, operating these businesses and assets through its subsidiaries and, if and when attractive exit valuations become available, disposing of these businesses and assets. The company conducts its business in five areas: property and casualty insurance and reinsurance, municipal bond reinsurance, capital solutions for asset and wealth management firms, property and casualty insurance distribution, and other operations.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.